Target intelligence / Profile preview

Toll-like receptor 5 (TLR5) (TLR5)

Target
TLR5
Molecular classification
Receptor, Pattern recognition receptor, Toll-like receptor family, NLR family
01

Overview

Toll-like receptor 5 (TLR5) is a transmembrane pattern-recognition receptor (PRR) that plays a critical role in the innate immune system by detecting bacterial flagellin, the primary protein component of bacterial flagella. It is expressed on various cells, including macrophages, dendritic cells, and intestinal epithelial cells, where it serves as a sentinel for motile bacterial pathogens. Upon flagellin binding, TLR5 dimerizes and recruits the MyD88 adapter protein, triggering a signaling cascade that activates the NF-κB transcription factor and induces the expression of pro-inflammatory cytokines and chemokines. In addition to extracellular recognition by TLR5, intracellular flagellin can be detected by the NLRC4 inflammasome via NAIP proteins, leading to caspase-1 activation and pyroptosis.

Therapeutically, TLR5 is a significant target for drug development, particularly as a site for vaccine adjuvants and radioprotectants. Agonists like Entolimod (CBLB502) have demonstrated the ability to protect hematopoietic and gastrointestinal tissues from lethal doses of radiation by activating NF-κB-mediated anti-apoptotic pathways. However, the therapeutic use of TLR5 modulators must be carefully managed due to the risk of systemic inflammatory responses or cytokine storms. Furthermore, while TLR5 activation can stimulate anti-tumor immunity, its role in cancer is complex, as it may also promote tumor progression in certain environments, such as the gut.

Other names
TLR5Toll-like receptor 5Flagellin receptorTIL3CD285NLRC4NLR family CARD domain-containing protein 4NAIPFlagellin-recognizing pattern-recognition receptors
02

Mechanism of action

TLR5 agonism activates the MyD88/NF-κB pathway to induce cytokines and survival signals; NLRC4 activation triggers the inflammasome and caspase-1.

03

Biological functions

Immune responseSignal transductionInflammatory responseCytokine productionApoptosis regulationPyroptosis
04

Disease associations

InfectionCancerInflammationRadiation injuryAutoimmune diseaseInflammatory bowel disease
05

Safety considerations

Systemic inflammatory response syndrome (SIRS)Cytokine stormImmunogenicityPotential tumor promotion
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Granulocyte colony-stimulating factor (G-CSF)NF-κB activationTLR5 expression

Beyond the preview

Go deeper on Toll-like receptor 5 (TLR5) (TLR5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toll-like receptor 5 (TLR5) (TLR5).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call